PADI2与人多种肿瘤的遗传易感性的关系
Relationship between PADI2 and genetic susceptibility in various human tumors

DOI: 10.6040/j.issn.1671-7554.0.2016.133

Keywords: 易感基因,肿瘤,基因分型,肽基精氨酸脱亚氨酶2,基因表达,
Susceptibility gene,Tumor,Gene expression,Peptidyl deiminase isoform 2,Genotype

Full-Text   Cite this paper   Add to My Lib

Abstract:

References

[1]	Wesche J, Kuhn S, Kessler BM, et al. Protein arginine methylation: a prominent modification and its demethylation[J]. Cell Mol Life Sci, 2017, 74(18): 3305-3315.
[2]	Tu R, Grover HM, Kotra LP. Peptidyl arginine deiminases and neurodegenerative diseases[J]. Curr Med Chem, 2016, 23(2):104-114.
[3]	McElwee JL, Mohanan S, Horibata S, et al. PAD2 overexpression in transgenic mice promotes spontaneous skin neoplasia[J]. Cancer Res, 2014, 74(21):6306-6317.
[4]	Shangkuan WC, Lin HC, Chang YT, et al. Risk analysis of colorectal cancer incidence by gene expression analysis[J]. PeerJ, 2017, 5: e3003. doi: 10.7717/peerj.3003.
[5]	McElwee JL, Mohanan S, Horibata S, et al. PAD2 overexpression in transgenic mice promotes spontaneous skin neoplasia[J]. Cancer Res, 2014, 74(21):6306-6317.
[6]	Briggs DJ, Skeeles JK. An enzyme-linked immunosorbent assay for detecting antibodies to Pasteurella multocida in chickens[J]. Avian Dis, 1984, 28(1):208-215.
[7]	Chang X, Fang K. PADI4 and tumourigenesis[J]. Cancer Cell Int, 2010, 10:7. doi: 10.1186/1475-2867-10-7.
[8]	McElwee JL, Mohanan S, Griffith OL, et al. Identification of PADI2 as a potential breast cancer biomarker and therapeutic target[J]. BMC Cancer, 2012, 12: 500. doi: 10.1186/1471-2407-12-500.
[9]	Cherrington BD, Morency E, Struble AM, et al. Potential role for peptidylarginine deiminase 2(PAD2)in citrullination of canine mammary epithelial cell histones[J]. PLoS One, 2010, 5(7): e11768. doi: 10.1371/journal.pone.0011768.
[10]	Cherrington BD, Zhang X, McElwee JL, et al. Potential role for PAD2 in gene regulation in breast cancer cells[J]. PLoS One, 2012, 7(7): e41242. doi: 10.1371/journal.pone.0041242.
[11]	Bhattacharya SK, Crabb JS, Bonilha VL, et al. Proteomics implicates peptidyl arginine deiminase 2 and optic nerve citrullination in glaucoma pathogenesis[J]. Invest Ophthalmol Vis Sci, 2006, 47(6):2508-2514.
[12]	Cantarino N, Musulen E, Valero V, et al. Downregulation of the deiminase PADI2 is an early event in colorectal carcinogenesis and indicates poor prognosis[J]. Mol Cancer Res, 2016, 14(9):841-848.
[13]	Wang H, Xu B, Zhang X, et al. PADI2 gene confers susceptibility to breast cancer and plays tumorigenic role via ACSL4, BINC3 and CA9 signaling[J]. Cancer Cell Int, 2016, 16:61. doi: 10.1186/s12935-016-0335-0.
[14]	Jiang Z, Cui Y, Wang L, et al. Investigating citrullinated proteins in tumour cell lines[J]. World J Surg Oncol, 2013, 11: 260. doi: 10.1186/1477-7819-11-260.
[15]	Slack JL, Causey CP, Thompson PR. Protein arginine deiminase 4: a target for an epigenetic cancer therapy[J]. Cell Mol Life Sci, 2011, 68(4):709-720.
[16]	Ying S, Dong S, Kawada A, et al. Transcriptional regulation of peptidylarginine deiminase expression in human keratinocytes[J]. J Dermatol Sci, 2009, 53(1): 2-9.
[17]	Cherrington BD, Mohanan S, Diep AN, et al. Comparative analysis of peptidylarginine deiminase-2 expression in canine, feline and human mammary tumours[J]. J Comp Pathol, 2012, 147(2-3): 139-146.
[18]	Chang X, Xia Y, Pan J, et al. PADI2 is significantly associated with rheumatoid arthritis[J]. PLoS One, 2013, 8(12): e81259. doi: 10.1371/journal.pone.0081259.
[19]	Mohanan S, Cherrington BD, Horibata S, et al. Potential role of peptidylarginine deiminase enzymes and protein citrullination in cancer pathogenesis[J]. Biochem Res Int, 2012: 895343. doi:10.1155/2012/895343.

Full-Text